Solara Active Pharma Sciences Committee Approves Final Call on Rights Shares
Solara Active Pharma Sciences Limited announced on March 24, 2026, that its Rights Issue Committee has approved the second and final call of ₹112.50 per equity share for partly-paid Rights Shares. This call includes ₹3.00 towards face value and ₹109.50 towards securities premium, as outlined in the Letter of Offer dated May 09, 2024.The Rights Issue Committee established April 02, 2026, as the Record date for determining holders of partly-paid Equity Shares who will receive the call notice for payment.
The Rights Issue Committee meeting was held on March 24, 2026, commencing at 9:30 A.M. and concluding at 9:55 A.M.
| Particulars | Remarks | |
|---|---|---|
| 1 | Forfeiture of shares | Not Applicable. |
| 2 | Reissue of forfeited shares or securities, or the issue of shares or securities held in reserve for future issue or the creation in any form or manner of new shares or securities or any other rights, privileges or benefits to subscribe to | Not Applicable. |
| 3 | Proposal to issue any class of securities; | Not Applicable |
| 4 | Alterations of capital, including calls; | Second &Final call of ₹112.50/- per equity shares ( ₹ 3.00/- towards face value and ₹ 109.50/- towards securities premium) per Rights Share in respect of partly paid Rights Shares, on Rights basis, pursuant to the Letter of Offer dated May 09, 2024. |
| 5 | Change in the terms regarding redemption/cancellation/retirement in whole or in part of any securities issued by the listed entity | Not Applicable |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.